Quarterly report · Q1
8095.TEDINET S100QLEN
Period2022-12-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.8bn | 2022-12-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.3bn | 2021-12-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | −¥92m | 2022-12-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥630m | 2021-12-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | −¥63m | 2022-12-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥660m | 2021-12-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | −¥85m | 2022-12-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥659m | 2021-12-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | −¥206m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥449m | 2021-12-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥208m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥449m | 2021-12-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥63.6bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥63.1bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.1bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2022-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.5bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.4bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.8bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2022-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥-5.24 | 2022-12-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.26 | 2021-12-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 41.5% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.4% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 59
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-02-28 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-02-28 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥55,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-02-28 | −¥23m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-02-28 | −¥430m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-02-28 | −¥430m |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-02-28 | ¥60m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥4.0bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥3.6bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥342m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-02-28 | −¥56m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-02-28 | −¥41m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥17m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-02-28 | −¥105m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥2.9bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥61m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | segment profit | 2022-12-01 → 2023-02-28 | ¥73m |
| —segment total | revenue | 2022-12-01 → 2023-02-28 | ¥13.2bn |
| —segment total | revenue external | 2022-12-01 → 2023-02-28 | ¥12.8bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥430m |
| —segment total | segment profit | 2022-12-01 → 2023-02-28 | −¥129m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-02-28 | ¥13.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-02-28 | ¥12.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥430m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-02-28 | −¥152m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-02-28 | −¥9m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-02-28 | −¥364m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-02-28 | −¥364m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-02-28 | ¥18m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-02-28 | ¥3.9bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-02-28 | ¥3.8bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-02-28 | ¥162m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-02-28 | ¥521m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-02-28 | ¥3.6bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-02-28 | ¥3.5bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-02-28 | ¥47m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-02-28 | −¥96m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-02-28 | ¥2.3bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-02-28 | ¥2.2bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-02-28 | ¥30m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-02-28 | ¥41m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-02-28 | ¥2.7bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-02-28 | ¥124m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-02-28 | ¥156m |
| —segment total | revenue | 2021-12-01 → 2022-02-28 | ¥12.6bn |
| —segment total | revenue external | 2021-12-01 → 2022-02-28 | ¥12.3bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-02-28 | ¥364m |
| —segment total | segment profit | 2021-12-01 → 2022-02-28 | ¥621m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-02-28 | ¥12.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-02-28 | ¥12.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-02-28 | ¥364m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-02-28 | ¥612m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 439
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | CurrentQuarterInstant | 27899848000 | JPY |
| Long term loans payable | Prior1YearInstant | 4777500000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 5233557000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 728789000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 701645000 | JPY |
| Provision for share based compensation ncl | Prior1YearInstant | 66255000 | JPY |
| Provision for share based compensation ncl | CurrentQuarterInstant | 66255000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 2570515000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 2608319000 | JPY |
| Other ncl | Prior1YearInstant | 547983000 | JPY |
| Other ncl | CurrentQuarterInstant | 573588000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 8691043000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 9183365000 | JPY |
| Liabilities | Prior1YearInstant | 36483118000 | JPY |
| Liabilities | CurrentQuarterInstant | 37083214000 | JPY |
| Capital stock | Prior1YearInstant | 4557400000 | JPY |
| Capital stock | CurrentQuarterInstant | 4557400000 | JPY |
| Capital surplus | Prior1YearInstant | 6538828000 | JPY |
| Capital surplus | CurrentQuarterInstant | 6545703000 | JPY |
| Retained earnings | Prior1YearInstant | 15031853000 | JPY |
| Retained earnings | CurrentQuarterInstant | 14454627000 | JPY |
| Treasury stock | Prior1YearInstant | -531722000 | JPY |
| Treasury stock | CurrentQuarterInstant | -531725000 | JPY |
| Shareholders equity | Prior1YearInstant | 25596360000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 25026005000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1007002000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 1028940000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -4026000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | 751000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 191067000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 205207000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 196203000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 141903000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1390246000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 1376802000 | JPY |
| Non controlling interests | Prior1YearInstant | 82094000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 102774000 | JPY |
| Net assets | Prior1YearInstant | 27068701000 | JPY |
| Net assets | CurrentQuarterInstant | 26505583000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 63551819000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 63588797000 | JPY |
| Net sales | Prior1YTDDuration | 12285735000 | JPY |
| Net sales | CurrentYTDDuration | 12785442000 | JPY |
| Cost of sales | Prior1YTDDuration | 8044002000 | JPY |
| Cost of sales | CurrentYTDDuration | 9198509000 | JPY |
| Gross profit | Prior1YTDDuration | 4241733000 | JPY |
| Gross profit | CurrentYTDDuration | 3586932000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 3611528000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 3678937000 | JPY |
| Operating income | Prior1YTDDuration | 630204000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |